US Lawyer Database

§ 26-4-202. [For Effective Date, See note.] Pedigrees for Prescription Drugs

Each person who is engaged in wholesale distribution of prescription drugs shall establish and maintain inventories and records of all transactions regarding the receipt and distribution or other disposition of the prescription drugs. These records shall include pedigrees for all prescription drugs that leave or have ever left the normal distribution channel in accordance with […]

§ 26-4-203. [For Effective Date, See note.] Violations; Falsified Prescription Drugs

If the board finds that there is a reasonable probability that: A wholesale distributor, other than a manufacturer, has: Violated a provision of this article; or Falsified a pedigree, provided a falsified pedigree, or sold, distributed, transferred, manufactured, repackaged, handled, or held a counterfeit prescription drug intended for human use; The prescription drug at issue […]

§ 26-4-117. Duty to Prosecute Violations

It shall be the duty of the prosecuting attorney of the court of competent jurisdiction to whom the board or some other person shall report a violation of this chapter to cause appropriate proceedings to be commenced and prosecuted for the enforcement of the penalties as in such case may be provided. The board, or […]

§ 26-4-118. Pharmacy Audit Bill of Rights; Recoupment of Disputed Funds; Appeals Process for Unfavorable Reports; Final Audit Report; Investigative Audits Based on Criminal Offenses

This Code section shall be known and may be cited as “The Pharmacy Audit Bill of Rights.” Notwithstanding any other law, when an audit of the records of a pharmacy is conducted by a managed care company, insurance company, third-party payor, pharmacy benefits manager, any entity licensed by the Department of Insurance, or any entity […]

§ 26-4-119. Pharmacy Anti-Steering and Transparency; Legislative Findings; Definitions; Prohibited Activities; Filing Disclosure Statement; Disciplinary Action; Application

This Code section shall be known and may be cited as the “Pharmacy Anti-Steering and Transparency Act.” The General Assembly finds that: The referral of a patient to a pharmacy by an affiliate for pharmacy care represents a potential conflict of interest; and These referral practices may limit or eliminate competitive alternatives in the health […]

§ 26-4-130. Dispensing Drugs; Compliance With Labeling and Packaging Requirements; Records Available for Inspection by Board; Renewal of Licenses

For purposes of this Code section, the term: “Drugs” means drugs as defined in this chapter and controlled substances as defined in Article 2 of Chapter 13 of Title 16. “Practitioner” or “practitioner of the healing arts” means, notwithstanding Code Section 26-4-5, a person licensed as a dentist, physician, podiatrist, or veterinarian under Chapter 11, […]

§ 26-4-140. Short Title

This article shall be known and may be cited as the “Third-party Prescription Program Law of 1983.” History. Code 1981, § 26-4-140 , enacted by Ga. L. 1998, p. 686, § 1.

§ 26-4-141. Legislative Findings

The General Assembly finds that certain practices are unfair to providers of pharmaceuticals, are burdensome and costly to those providers, result in unfair increased costs to certain consumers, and threaten the availability of pharmaceuticals to the public. The General Assembly further finds that there is a need for regulation of certain practices engaged in by […]